These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9210691)

  • 1. Effect of severity of meningitis on fungicidal activity of flucytosine combined with fluconazole in a murine model of cryptococcal meningitis.
    Ding JC; Bauer M; Diamond DM; Leal MA; Johnson D; Williams BK; Thomas AM; Najvar L; Graybill JR; Larsen RA
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1589-93. PubMed ID: 9210691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphotericin B and fluconazole, a potent combination therapy for cryptococcal meningitis.
    Larsen RA; Bauer M; Thomas AM; Graybill JR
    Antimicrob Agents Chemother; 2004 Mar; 48(3):985-91. PubMed ID: 14982793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of fluconazole on fungicidal activity of flucytosine in murine cryptococcal meningitis.
    Larsen RA; Bauer M; Weiner JM; Diamond DM; Leal ME; Ding JC; Rinaldi MG; Graybill JR
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2178-82. PubMed ID: 8878602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphotericin B colloidal dispersion combined with flucytosine with or without fluconazole for treatment of murine cryptococcal meningitis.
    Diamond DM; Bauer M; Daniel BE; Leal MA; Johnson D; Williams BK; Thomas AM; Ding JC; Najvar L; Graybill JR; Larsen RA
    Antimicrob Agents Chemother; 1998 Mar; 42(3):528-33. PubMed ID: 9517927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy with fluconazole and flucytosine in the murine model of cryptococcal meningitis.
    Nguyen MH; Najvar LK; Yu CY; Graybill JR
    Antimicrob Agents Chemother; 1997 May; 41(5):1120-3. PubMed ID: 9145879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of fluconazole singly and in combination with 5-fluorocytosine or amphotericin B in the treatment of cryptococcal meningoencephalitis in an intracranial murine model.
    Hossain MA; Mukherjee PK; Reyes G; Long L; Ghannoum MA
    J Chemother; 2002 Aug; 14(4):351-60. PubMed ID: 12420852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi.
    Nussbaum JC; Jackson A; Namarika D; Phulusa J; Kenala J; Kanyemba C; Jarvis JN; Jaffar S; Hosseinipour MC; Kamwendo D; van der Horst CM; Harrison TS
    Clin Infect Dis; 2010 Feb; 50(3):338-44. PubMed ID: 20038244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular epidemiology and antifungal susceptibility of Cryptococcus neoformans isolates from Ugandan AIDS patients.
    Pfaller M; Zhang J; Messer S; Tumberland M; Mbidde E; Jessup C; Ghannoum M
    Diagn Microbiol Infect Dis; 1998 Nov; 32(3):191-9. PubMed ID: 9884835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of experimental cryptococcal meningitis with fluconazole: impact of dose and addition of flucytosine on mycologic and pathophysiologic outcome.
    Kartalija M; Kaye K; Tureen JH; Liu Q; Täuber MG; Elliott BR; Sande MA
    J Infect Dis; 1996 May; 173(5):1216-21. PubMed ID: 8627075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluconazole alone or combined with flucytosine for the treatment of AIDS-associated cryptococcal meningitis.
    Milefchik E; Leal MA; Haubrich R; Bozzette SA; Tilles JG; Leedom JM; McCutchan JA; Larsen RA
    Med Mycol; 2008 Jun; 46(4):393-5. PubMed ID: 18415850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings.
    Sloan D; Dlamini S; Paul N; Dedicoat M
    Cochrane Database Syst Rev; 2008 Oct; (4):CD005647. PubMed ID: 18843697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined therapy with fluconazole and flucytosine in murine cryptococcal meningitis.
    Allendoerfer R; Marquis AJ; Rinaldi MG; Graybill JR
    Antimicrob Agents Chemother; 1991 Apr; 35(4):726-9. PubMed ID: 2069378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries.
    Loyse A; Burry J; Cohn J; Ford N; Chiller T; Ribeiro I; Koulla-Shiro S; Mghamba J; Ramadhani A; Nyirenda R; Aliyu SH; Wilson D; Le T; Oladele R; Lesikari S; Muzoora C; Kalata N; Temfack E; Mapoure Y; Sini V; Chanda D; Shimwela M; Lakhi S; Ngoma J; Gondwe-Chunda L; Perfect C; Shroufi A; Andrieux-Meyer I; Chan A; Schutz C; Hosseinipour M; Van der Horst C; Klausner JD; Boulware DR; Heyderman R; Lalloo D; Day J; Jarvis JN; Rodrigues M; Jaffar S; Denning D; Migone C; Doherty M; Lortholary O; Dromer F; Stack M; Molloy SF; Bicanic T; van Oosterhout J; Mwaba P; Kanyama C; Kouanfack C; Mfinanga S; Govender N; Harrison TS
    Lancet Infect Dis; 2019 Apr; 19(4):e143-e147. PubMed ID: 30344084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial.
    Brouwer AE; Rajanuwong A; Chierakul W; Griffin GE; Larsen RA; White NJ; Harrison TS
    Lancet; 2004 May; 363(9423):1764-7. PubMed ID: 15172774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphotericin B with or without flucytosine followed by fluconazole as primary therapy for cryptococcal meningitis in patients with AIDS.
    Jaruratanasirikul S
    Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):719-23. PubMed ID: 9253873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluconazole plus flucytosine is a good alternative therapy for non-HIV and non-transplant-associated cryptococcal meningitis: A retrospective cohort study.
    Li Z; Liu Y; Chong Y; Li X; Jie Y; Zheng X; Yan Y
    Mycoses; 2019 Aug; 62(8):686-691. PubMed ID: 31120606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triple therapy combined with ventriculoperitoneal shunts can improve neurological function and shorten hospitalization time in non-HIV cryptococcal meningitis patients with increased intracranial pressure.
    Li M; Liu J; Deng X; Gan Q; Wang Y; Xu X; Jiang Y; Peng F
    BMC Infect Dis; 2020 Nov; 20(1):844. PubMed ID: 33198666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of murine cryptococcal meningitis with UR-9751 and UR-9746.
    Restrepo MI; Najvar LK; Barchiesi F; Luther MF; Graybill JR
    Med Mycol; 2000 Jun; 38(3):221-4. PubMed ID: 10892990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of patients with acute AIDS-associated cryptococcal meningitis who can be effectively treated with fluconazole: the role of antifungal susceptibility testing.
    Witt MD; Lewis RJ; Larsen RA; Milefchik EN; Leal MA; Haubrich RH; Richie JA; Edwards JE; Ghannoum MA
    Clin Infect Dis; 1996 Feb; 22(2):322-8. PubMed ID: 8838190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of flucytosine and fluconazole combined with amphotericin B for the treatment of HIV-associated cryptococcal meningitis: a systematic review and meta-analysis.
    Yao ZW; Lu X; Shen C; Lin DF
    Eur J Clin Microbiol Infect Dis; 2014 Aug; 33(8):1339-44. PubMed ID: 24550039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.